Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 USD | +0.73% | +3.00% | +28.50% |
04-24 | Transcript : Lantern Pharma Inc. - Special Call | |
04-22 | Lantern Gets Regulatory Approval in Japan, Taiwan for Non-Small Cell Lung Cancer Trial Expansion | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.50% | 59.08M | |
+1.51% | 42.75B | |
+48.15% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Lantern Pharma : to Join Forces With Brain Cancer Program at Johns Hopkins to Further Develop Brain Cancer Drug Candidate LP-184